Hikma's Eatontown plant cleared by FDA
This article was originally published in Scrip
Executive Summary
The US FDA has lifted the warning letter issued in February 2012 that shut Hikma Pharmaceuticals' Eatontown manufacturing facility in New Jersey, which provides oral products for the US market.